VERASTEM ONCOLOGY

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

#SimilarOrganizations #People #Financial #Event #Website #More

VERASTEM ONCOLOGY

Social Links:

Facebook

Linkedin

Twitter

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2010-01-01

Address:

Needham, Massachusetts, United States

Country:

United States

Website Url:

http://www.verastem.com

Total Employee:

101+

Status:

Active

Contact:

1-781-292-4200

Email Addresses:

[email protected]

Total Funding:

220 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome

Similar Organizations

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

Current Advisors List

michael-kauffman_image

Michael Kauffman Lead Director @ Verastem Oncology
Board_member
2014-01-01

timothy-j-barberich_image

Timothy J. Barberich Member of the Board of Directors @ Verastem Oncology
Board_member
2014-03-01

alison-lawton_image

Alison Lawton Board Of Directors @ Verastem Oncology
Board_member

brian-stuglik_image

Brian Stuglik Board of Directors, Member @ Verastem Oncology
Board_member
2017-01-01

not_available_image

Bruce Wendel Board Member @ Verastem Oncology
Board_member

ambar-bhattacharyya_image

Ambar Bhattacharyya Former Board Observer @ Verastem Oncology
Board_observer

stephen-kraus_image

Stephen Kraus Board Member @ Verastem Oncology
Board_member

richard-aldrich_image

Richard Aldrich Member of the Board of Directors @ Verastem Oncology
Board_member

Current Employees Featured

brian-stuglik_image

Brian Stuglik
Brian Stuglik CEO @ Verastem Oncology
CEO
2019-07-01

jonathan-pachter_image

Jonathan Pachter
Jonathan Pachter Chief Scientific Officer @ Verastem Oncology
Chief Scientific Officer
2016-04-01

dan-paterson_image

Dan Paterson
Dan Paterson President & Chief Operating Officer @ Verastem Oncology
President & Chief Operating Officer
2014-01-01

robert-gagnon_image

Robert Gagnon
Robert Gagnon Chief Business and Financial Officer @ Verastem Oncology
Chief Business and Financial Officer
2018-01-01

christoph-westphal_image

Christoph Westphal
Christoph Westphal Founder & Executive Chairman @ Verastem Oncology
Founder & Executive Chairman

louis-j-denis_image

Louis J. Denis
Louis J. Denis Chief Medical Officer @ Verastem Oncology
Chief Medical Officer
2021-09-01

Founder

christoph-westphal_image

Christoph Westphal

michelle-dipp_image

Michelle Dipp

Stock Details

Company's stock symbol is NASDAQ:VSTM

Investors List

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Verastem Oncology

herculescapital_image

Hercules Capital

Hercules Capital investment in Post-IPO Debt - Verastem Oncology

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series C - Verastem Oncology

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - Verastem Oncology

longwood-founders-fund_image

Longwood Fund

Longwood Fund investment in Series C - Verastem Oncology

cardinal-partners_image

Cardinal Partners

Cardinal Partners investment in Series C - Verastem Oncology

astellas-venture-management_image

Astellas Venture Management

Astellas Venture Management investment in Series B - Verastem Oncology

bessemer-venture-partners_image

Bessemer Venture Partners

Bessemer Venture Partners investment in Series B - Verastem Oncology

mpm-capital_image

MPM Capital

MPM Capital investment in Series B - Verastem Oncology

cardinal-partners_image

Cardinal Partners

Cardinal Partners investment in Series B - Verastem Oncology

Key Employee Changes

Date	New article
2021-09-22	Verastem Oncology Appoints Louis J. Denis, M.D., as Chief Medical Officer

Official Site Inspections

http://www.verastem.com Semrush global rank: 4.91 M Semrush visits lastest month: 1.77 K

Host Informations
Whois Informations

Loading ...

More informations about "Verastem Oncology" on Search Engine